HDAC9 and cancer: Based on the mechanism, we hypothesize the synergistic beneficial effects of ubenimex and the pan HDAC inhibitor Quisinostat, which was reported to inhibit cancer cells self‐renewal and the growth of medulloblastoma.33, 34